Nos2 Rat shRNA Plasmid (Locus ID 24599)

SKU
TL709254
Nos2 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
  $1,013.00
In Stock*
Specifications
Specifications
Product Data
Locus ID 24599
Synonyms iNos; Nos2a
Vector pGFP-C-shLenti
E. coli Selection Chloramphenicol (34 ug/ml)
Mammalian Cell Selection Puromycin
Format Lentiviral plasmids
Components Nos2 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 24599). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq NM_012611, NM_012611.1, NM_012611.2, NM_012611.3
UniProt ID Q06518
Summary cytokine-inducible enzmyme involved in nitric oxide (NO) production RGD, Feb 2006
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung
Murphy, Treacy, Lynch et al
FASEB J. (2019)
AI Summary: OriGene contributed to this study by providing the Nos2-shRNA Lenti-plasmid and the scrambled-shRNA Lenti-plasmid, which were used to manipulate gene expression and investigate the role of nitric oxide in the immunomodulatory effects of mesenchymal stromal cells.
Snippet: Rat short hairpin RNA (shRNA) expression vectors in pGFP-C-shLenti plasmids (Nos2-shRNA Lenti-plasmid) and 1 scrambled negative control noneffective shRNA cassette in pGFP-C-shLenti plasmid (scrbl-shRNA Lenti-plasmid) were purchased from OriGene (Rockville
Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype
Shen, Burguillos, Osman et al
Nat. Immunol. (2016)
Cited by 105
AI Summary: OriGene’s Nos2-targeting shRNA and non-targeting shRNA were used to manipulate NOS2 expression in glioma cells, enabling the study of its role in microglia-mediated tumor support.
Snippet: Phoenix cells were transfected with vectors encoding Nos2-targeting shRNA or non-targeting shRNA (Origene technologies)
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products